← Browse by Condition
Medical Condition

multiple system atrophy

Total Trials
7
Recruiting Now
7
Trial Phases
Phase 2

ClinicalMetric tracks all active clinical trials for multiple system atrophy sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — multiple system atrophy Clinical Trials

How many clinical trials are currently recruiting for multiple system atrophy?
ClinicalMetric currently tracks 7 actively recruiting clinical trials for multiple system atrophy, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 7. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for multiple system atrophy?
multiple system atrophy research spans Phase 2 (2 trials). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a multiple system atrophy clinical trial?
Eligibility criteria for multiple system atrophy trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Trial Phases
Phase 2
2
Top Sponsors
Beijing Tiantan Hospital 1 trial
NYU Langone Health 1 trial
Sanford Health 1 trial
Kliniken Beelitz GmbH 1 trial
Teva Branded Pharmaceutical Products R&D LLC 1 trial

Recruiting Clinical Trials

NCT07392411
Recruiting
Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Biomarkers
Enrollment
720 pts
Location
China
Sponsor
Beijing Tiantan Hospital
View Trial →
NCT01799915
Recruiting
Natural History Study of Synucleinopathies
Enrollment
800 pts
Location
United States, Argen...
Sponsor
NYU Langone Health
View Trial →
NCT01793168
Recruiting
Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Enrollment
20,000 pts
Location
United States
Sponsor
Sanford Health
View Trial →
NCT04706234
Recruiting
Systematic Assessment of Laryngopharyngeal Function in Patients With Neurodegenerative Diseases
Enrollment
350 pts
Location
Austria, Germany, Is...
Sponsor
Kliniken Beelitz GmbH
View Trial →
NCT07197866 Phase 2
Recruiting
An Extension Trial to Test if TEV-56286 is Effective in Relieving Multiple System Atrophy
Enrollment
200 pts
Location
United States, Franc...
Sponsor
Teva Branded Pharmaceutical Pr...
View Trial →
NCT03042988
Recruiting
Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension
Enrollment
20 pts
Location
United States
Sponsor
Vanderbilt University Medical ...
View Trial →
NCT06868628 Phase 2
Recruiting
A Phase 2a Study of Foralumab Nasal in Patients With Multiple System Atrophy (MSA)
Enrollment
5 pts
Location
United States
Sponsor
Tiziana Life Sciences LTD
View Trial →

Related Conditions

pure autonomic failure (2) parkinson disease (2) beta mannosidosis (2) parkinson s disease (1) progressive supranuclear palsy psp (1) healthy control (1) patients with synucleinopathies (1) neurogenic orthostatic hypotension (1) rem sleep behavior disorder (1) dementia with lewy bodies (1) shy drager disease (1) rare disorders (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology